FDA Approves Bard’s Lutonix DEB
C.R. Bard ($BCR) won a unanimous vote from an FDA advisory panel for its drug-eluting balloon catheter, setting the stage for the device’s full regulatory approval. The FDA’s Circulatory System Devices Advisory Panel recommended that the company’s Lutonix drug-coated balloon PTA catheter (DCB) be approved in the U.S. to treat peripheral artery disease (PAD) by…